UNSPSC 51152201: Dextrose/mivacurium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class MS300. This VA Drug Class (MS300) classifies this compound as belonging to the group NEUROMUSCULAR BLOCKING AGENTS.

UNSPSC 51152201 Dextrose/mivacurium chloride is a Commodity code showing minimal alignment with recent state and local procurement activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems for community health support, not the pharmaceutical compounds the code nominally describes. The mismatch suggests either a data classification error at the issuing level or a case of a jurisdiction applying an incorrect UNSPSC tag to a health-supply procurement that falls outside this code's actual scope.

The Seminole County opportunity, due July 26, 2023, calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, delivered quarterly to the Seminole County Community Health Building in Sanford, Florida, with all shipping included in bid pricing. Vendors must provide electronic bids through the county's e-Procurement Portal, hold E-Verify authorization, and comply with drug-free workplace certification and insurance requirements including workers' compensation and commercial general liability. The contract is structured as a two-year initial term with one-year renewal option and carries a three-month probationary termination clause. Potential FEMA funding introduces Clean Air Act and Federal Water Pollution Control Act compliance requirements. No set-aside designations for disadvantaged enterprises appear in the procurement. This code shows no other recent state or local opportunities in the available dataset, making it difficult to characterize issuing-body patterns or geographic concentration beyond this single Florida county activity.